Merck & Co Inc (MRK)

64.35
2.00 3.20
NYSE : Health Care
Prev Close 62.36
Open 62.31
Day Low/High 61.72 / 62.34
52 Wk Low/High 57.18 / 66.80
Volume 9.37M
Avg Volume 8.78M
Exchange NYSE
Shares Outstanding 2.74B
Market Cap 170.56B
EPS 1.40
P/E Ratio 39.72
Div & Yield 1.88 (3.00%)

Latest News

Merck Announces Fourth-Quarter 2017 Dividend

Merck Announces Fourth-Quarter 2017 Dividend

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the Board of Directors has declared a quarterly dividend of $0.

Senate Votes to Approve Motion to Proceed on Health Care

Senate Votes to Approve Motion to Proceed on Health Care

Majority Leader Mitch McConnell needed 50 out of the 52 Senate Republicans to support him.

Senate Poised to Hold Procedural Vote on Health Care

Senate Poised to Hold Procedural Vote on Health Care

Majority Leader Mitch McConnell needs 50 out of the 52 Senate Republicans to support him.

Merck's Investigational NNRTI, Doravirine, Meets Primary Efficacy Endpoint Of Non-Inferiority To Efavirenz, Both In Combination With Other Antiretroviral Agents, In Pivotal Phase 3 Trial For Treatment Of HIV-1 Infection

Merck's Investigational NNRTI, Doravirine, Meets Primary Efficacy Endpoint Of Non-Inferiority To Efavirenz, Both In Combination With Other Antiretroviral Agents, In Pivotal Phase 3 Trial For Treatment Of HIV-1 Infection

Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the presentation of results from the DRIVE-AHEAD study, the second of two pivotal Phase 3 clinical trials evaluating the efficacy and...

Merck Provides Update On Phase 3 Study Of KEYTRUDA® (pembrolizumab) Monotherapy In Patients With Previously Treated Recurrent Or Metastatic Head And Neck Squamous Cell Carcinoma (HNSCC)

Merck Provides Update On Phase 3 Study Of KEYTRUDA® (pembrolizumab) Monotherapy In Patients With Previously Treated Recurrent Or Metastatic Head And Neck Squamous Cell Carcinoma (HNSCC)

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the pivotal phase 3 KEYNOTE-040 trial investigating KEYTRUDA ® (pembrolizumab), the company's anti-PD-1 therapy, in previously...

FedEx Expects Financial Hit From Cyber Hack; Here's Who Else Who Could Feel Petya's Pain

FedEx Expects Financial Hit From Cyber Hack; Here's Who Else Who Could Feel Petya's Pain

FedEx joined snack-maker Mondelez among firms warning that the late-June hacks will affect their numbers.

Merck Announces U.S. Launch Of RENFLEXIS™ (infliximab-abda), A Biosimilar Of Remicade, For All Eligible Indications

Merck Announces U.S. Launch Of RENFLEXIS™ (infliximab-abda), A Biosimilar Of Remicade, For All Eligible Indications

Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the U.

Merck Announces Week 96 Results From ONCEMRK, A Study Evaluating Once-Daily ISENTRESS® HD (raltegravir), In Combination With Other Antiretroviral Agents, For The Treatment Of HIV-1 Infection In Appropriate Patients

Merck Announces Week 96 Results From ONCEMRK, A Study Evaluating Once-Daily ISENTRESS® HD (raltegravir), In Combination With Other Antiretroviral Agents, For The Treatment Of HIV-1 Infection In Appropriate Patients

Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the presentation of Week 96 results from the pivotal Phase 3 ONCEMRK study evaluating the efficacy and safety of ISENTRESS HD 1, a 1200 mg...

U.S. Economy Is Probably Limping Along Because of Frustrating Consumers: Week Ahead

U.S. Economy Is Probably Limping Along Because of Frustrating Consumers: Week Ahead

Wall Street's first glimpse at the second quarter.

European Medicines Agency's CHMP Recommends Approval For Merck's KEYTRUDA® (pembrolizumab) For The Treatment Of Certain Patients With Locally Advanced Or Metastatic Urothelial Carcinoma, A Type Of Bladder Cancer

European Medicines Agency's CHMP Recommends Approval For Merck's KEYTRUDA® (pembrolizumab) For The Treatment Of Certain Patients With Locally Advanced Or Metastatic Urothelial Carcinoma, A Type Of Bladder Cancer

Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion...

Merck Announces U.S. FDA Grants Tentative Approval For LUSDUNA™ Nexvue™ (insulin Glargine Injection), A Follow-On Biologic Basal Insulin

Merck Announces U.S. FDA Grants Tentative Approval For LUSDUNA™ Nexvue™ (insulin Glargine Injection), A Follow-On Biologic Basal Insulin

Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced that the U.

Merck Announces Presentations Of Clinical And Real-World Data At The Alzheimer's Association International Conference®

Merck Announces Presentations Of Clinical And Real-World Data At The Alzheimer's Association International Conference®

Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced the presentation of data at The Alzheimer's Association International Conference taking place in London, July 16-20, 2017.

Dow Scores Record Close as Retail Roars Higher, Walmart Rallies

Dow Scores Record Close as Retail Roars Higher, Walmart Rallies

Upbeat guidance from Target inspires retail rally.

Dow on Track for Record Close as Retail Roars Higher, Walmart Rallies

Dow on Track for Record Close as Retail Roars Higher, Walmart Rallies

Upbeat guidance from Target inspires retail rally.

Healthcare Stocks Sell Off, Retail Rallies on Upbeat Guidance From Target

Healthcare Stocks Sell Off, Retail Rallies on Upbeat Guidance From Target

Upbeat guidance from Target inspires retail rally.

Merck Becomes #25 Most Shorted Dow Stock, Replacing Cisco Systems

The most recent short interest data has been released for the 06/30/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Dow Jones Industrial Average by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Cyber Attack Likely Cost Saint-Gobain 1% of First Half Sales

Cyber Attack Likely Cost Saint-Gobain 1% of First Half Sales

The French building firm probably lost about $230 million of sales from the cyber attack but said it might make some of them back in the third quarter.

Landmark Novartis Immunotherapy Faces Crucial FDA Hearing Wednesday

Landmark Novartis Immunotherapy Faces Crucial FDA Hearing Wednesday

FDA advisory committee poised to make recommendation regarding CAR T therapy from Novartis that represents the first possibility of treatment calling on the body's own engineered cells to attack cancer.

What the FDA's Hold on 3 Merck Studies Means for Other Drug Makers

What the FDA's Hold on 3 Merck Studies Means for Other Drug Makers

The FDA has placed a clinical hold on three combination studies of Merck's Keytruda in multiple myeloma.

Merck To Hold Second-Quarter 2017 Sales And Earnings Conference Call On July 28

Merck To Hold Second-Quarter 2017 Sales And Earnings Conference Call On July 28

Merck (NYSE: MRK), known as MSD outside the United States and Canada, will hold its second-quarter 2017 sales and earnings conference call with institutional investors and analysts at 8:00 a.

Merck To Present New Data From Clinical Trials Evaluating ISENTRESS® HD (raltegravir) And Investigational HIV Therapies Doravirine And MK-8591 At IAS 2017

Merck To Present New Data From Clinical Trials Evaluating ISENTRESS® HD (raltegravir) And Investigational HIV Therapies Doravirine And MK-8591 At IAS 2017

Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that new data from the company's HIV portfolio and pipeline are scheduled to be presented at the 9th IAS Conference on HIV Science (IAS...

Merck Provides Further Update On Three Multiple Myeloma Studies Evaluating KEYTRUDA® (pembrolizumab) In Combination With Pomalidomide Or Lenalidomide

Merck Provides Further Update On Three Multiple Myeloma Studies Evaluating KEYTRUDA® (pembrolizumab) In Combination With Pomalidomide Or Lenalidomide

Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.

First Witness to Testify in Pharma Bro's Trial Felt 'Betrayed'

First Witness to Testify in Pharma Bro's Trial Felt 'Betrayed'

Sarah Hassan, daughter of pharmaceutical executive Fred Hassan, was ignored by Shkreli for nearly a year before she received returns on her original investment.

5 Things You Must Know Before the Market Opens Wednesday

5 Things You Must Know Before the Market Opens Wednesday

U.S. stock futures point to a mixed start for Wall Street on Wednesday, June 28.

Computer Virus Spreads to U.S., Hits Merck - Report

Computer Virus Spreads to U.S., Hits Merck - Report

A computer virus that locks up computers and seeks ransom payments has spread to the U.S.